Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells.
Trinh A, Khamari R, Fovez Q, Mahon FX, Turcq B, Bouscary D, Maboudou P, Joncquel M, Coiteux V, Germain N, Laine W, Dekiouk S, Jean-Pierre S, Maguer-Satta V, Ghesquiere B, Idziorek T, Quesnel B, Kluza J, Marchetti P.
Trinh A, et al. Among authors: germain n.
Mol Metab. 2022 Jan;55:101410. doi: 10.1016/j.molmet.2021.101410. Epub 2021 Dec 1.
Mol Metab. 2022.
PMID: 34863941
Free PMC article.